Print this page
Site Map
Appointments
Fax
By postDr See Kwok - MBChB, FRCGP, DRCOG, MD
Date qualified: 1978 (Leeds)
Joined Practice: 1983
Practice Interests: Coronary Heart Disease, Hypertension, Minor surgery, Hormone replacement therapy, Lipids
Outside Interests: Clinical Research Fellow, Lipoprotein Research Group, University of Manchester.
Publications:
- Seneviratne CJ, France MW, Kwok S, Tunbridge RD. Reporting lipid results with associated assessment of cardiovascular risk. In: Martin SM, ed. Proceedings of the ACB National Meeting. London: Association of Clinical Biochemists, 2001: 101.
- Kwok S, France MW, Seneviratne CJ, Tunbridge RD. Heartache for South Asians. In: Martin SM, ed. Proceedings of the ACB National Meeting. London: Association of Clinical Biochemists, 2001: 102.
- Drummond A, Kwok S, Morgan J, Durrington PN. Costs of aspirin and statins in general practice. Q J Med 2002: 95:23-26.
- Green R, Kwok S, Durrington PN. Preventing cardiovascular disease in hypertension: effects of lowering blood pressure and cholesterol. Q J Med 2002; 95:821-826.
- Menys VC, Liu Y, Mackness MI, Caslake MJ, Kwok S, Durrington PN. Measurement of plasma small-dense LDL concentration by a simplified ultracentrifugation procedure and immunoassay of apolipoprotein B. Clin Chim Acta 2003 (334):95-106.
- France MW, Kwok S, McElduff P, Seneviratne CJ. Ethnic trends in lipid tests in general practice. Q J Med 2003; 96:919-923.
- Menys VC, Liu Y, Mackness MI, Kwok S, Caslake MJ, Stewart G, Durrington PN. Isolation of plasma small-dense low-density lipoprotein using a simple air-driven ultracentrifuge and quantification using immunoassay of apolipoprotein B. Clin Chem Lab Med 2004;42(1):30-36.
- Singh N, Kwok S, Seneviratne CJ, France M, Durrington P.'The National Cholesterol Education Program III scoring system for CHD risk estimation cannot be used with European recommendations' Br J Cardiol 2004;11:282-6.
- Kwok S, Selby PL, McElduff P, Laing I, Mackness B, Mackness MI, Prais H, Morgan J, Yates AP, Durrington PN. 'Progestogens of varying androgenicity and cardiovascular risk factors in postmenopausal women receiving oestrogen replacement therapy.' Clin Endo 2004;61:760-767.
- Kwok S, Selby P, McElduff P, Mackness B, Mackness M, Durrington P. Effects of progestins of varying androgenicity on lipoproteins and paraoxonase in postmenopausal women receiving estrogen . Circulation 2005;111(4):e-63.
- Kwok S, McElduff P, Ashton D, Lowe G, Humphries S, Wood D, Durrington D. Cardiovascular risk factors and hormone use in women: the United Kingdom Women's Heart Study (UKWHS) . Circulation 2005;111(4):e-64.
- Kwok S, Best Practice in the treatment of the dyslipidaemic postmenopausal women. Trends in Urology Gynaecology & Sexual Health 2005;10(5):5-6
- Kwok S, Charlton-Menys V, Pemberton P, McElduff, Durrington PN. Effects of dydrogesterone and norethisterone, in combination with oestradiol, on lipoproteins and inflammatory markers in postmenopausal women. Maturitas 2006;(4):439-446
- Beeharry D, Coupe B, Benbow E, Morgan J, Kwok S, Charlton-Menys V, France M, Durrington PN. Familial hypercholesterolaemia commonly presents with achilles tenosynovitis. Ann Rheum Dis 2006;65(3):312-5
